CLL

MD IQ

Conference Coverage

`Remarkable’: CAR T therapy for CLL/SLL

Primary analysis of the TRANSCEND CLL 004 trial showed that a single dose of CAR T therapy achieved durable responses in CLL and SLL, with a...

Latest News

Drug shortages in U.S. at 10-year high

Among the top five drug classes affected by shortages are chemotherapy drugs used in the treatment of cancer, many of which do not have...

Pages